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Abstract: In order to create near-infrared (NIR) luminescent lanthanide complexes suitable for
DNA-interaction, novel lanthanide dppz complexes with general formula [Ln(NO3)3(dppz)2]
(Ln = Nd3+, Er3+ and Yb3+; dppz = dipyrido[3,2-a:2′,3′-c]phenazine) were synthesized, characterized
and their luminescence properties were investigated. In addition, analogous compounds with
other lanthanide ions (Ln = Ce3+, Pr3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Tm3+, Lu3+) were prepared.
All complexes were characterized by IR spectroscopy and elemental analysis. Single-crystal X-ray
diffraction analysis of the complexes (Ln = La3+, Ce3+, Pr3+, Nd3+, Eu3+, Er3+, Yb3+, Lu3+) showed that
the lanthanide’s first coordination sphere can be described as a bicapped dodecahedron, made up of
two bidentate dppz ligands and three bidentate-coordinating nitrate anions. Efficient energy transfer
was observed from the dppz ligand to the lanthanide ion (Nd3+, Er3+ and Yb3+), while relatively high
luminescence lifetimes were detected for these complexes. In their excitation spectra, the maximum of
the strong broad band is located at around 385 nm and this wavelength was further used for excitation
of the chosen complexes. In their emission spectra, the following characteristic NIR emission peaks
were observed: for a) Nd3+: 4F3/2 → 4I9/2 (870.8 nm), 4F3/2 → 4I11/2 (1052.7 nm) and 4F3/2 → 4I13/2
(1334.5 nm); b) Er3+: 4I13/2 → 4I15/2 (1529.0 nm) c) Yb3+: 2F5/2 → 2F7/2 (977.6 nm). While its low
triplet energy level is ideally suited for efficient sensitization of Nd3+ and Er3+, the dppz ligand is
considered not favorable as a sensitizer for most of the visible emitting lanthanide ions, due to its
low-lying triplet level, which is too low for the accepting levels of most visible emitting lanthanides.
Furthermore, the DNA intercalation ability of the [Nd(NO3)3(dppz)2] complex with calf thymus
DNA (CT-DNA) was confirmed using fluorescence spectroscopy.
Keywords: lanthanide complexes; dipyrido[3,2-a:2′,3′-c]phenazine; crystal structures; NIR luminescence
1. Introduction
Lanthanide chemistry is a field of inorganic chemistry that is constantly evolving, particularly in
recent decades, as a growing number of synthesized compounds are widely used in different areas.
One of the most fascinating aspects of trivalent lanthanides is their unique luminescence properties [1–3].
They show characteristic narrow line-like emission peaks, ranging from the UV-visible (UV/Vis) to
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near-infrared (NIR), and in suitable hosts even in the mid-infrared (MIR) region, exhibiting relatively
long luminescence lifetimes. Yet, a downside of trivalent lanthanides is that their f -f transitions
are parity forbidden, and therefore their absorption coefficients are very low. This results in low
emission intensities unless the compound is excited with high power sources, e.g., lasers. The design
of lanthanide complexes with organic ligands, which are strongly absorbing chromophores, is an ideal
way to overcome this drawback.
The unique properties (structural, optical and magnetic) of the lanthanide complexes allow them
to be used in a wide range of applications [4]. In the field of biology and medicine these complexes are
particularly investigated [5]. They are already being employed or show great potential as MRI contrast
agents (Gd3+ compounds), fluorescent probes and bioresponsive cellular imaging agents, as well
as artificial nucleases for cleavage of RNA or DNA [6–8]. Recently, studies have shown that other
lanthanide compounds, such as oxide nanoparticles (e.g., CeO2), nanodrums and nanocrystals, as well
as radioisotopes (e.g., 177Lu), represent very promising agents in cancer imaging and therapy [9,10].
Lanthanides usually have the +3 oxidation state and the significant redox stability of this oxidation
state is very important for cellular applications, especially for hypoxic cancer cells [5]. The ability
of rapid ligand exchange rates and strong Lewis acidity of the trivalent lanthanide ions and their
complexes make them suitable in application as artificial nucleases for cleavage of RNA or DNA.
This study originated from our interest to design lanthanide complexes, which are highly emissive
in the NIR region (780–2500 nm wavelength). In the aspect of biological applications, luminescent
materials emitting in the NIR region of the electromagnetic spectrum have several advantages over
visible emitting materials. Among the most important is that they are safer for biological tissues and
result in better optical imaging resolution [11]. Biological tissue is also more transparent for NIR
light than for visible or UV light, hence allowing imaging of deeper-lying tumor cells. Several of the
trivalent lanthanide ions show NIR emission, given the right circumstances, such as Er3+, Ho3+, Tm3+,
Pr3+, Yb3+, Nd3+, Sm3+ and Dy3+ [12]. Among them, Nd3+, Er3+ and Yb3+ are most often investigated.
Many efforts have already been invested in the design of relatively stable complexes of
f-elements, which can be photoactivated upon light irradiation [13–16]. However, the design
of highly emissive lanthanide complexes in the NIR region can be quite challenging and the
choice of an appropriate organic ligand is crucial. We have focused our work on the design of
lanthanide complexes with dipyrido[3,2-a:2′,3′-c]phenazine (dppz) as its triplet level is ideally suited
for efficient sensitization of Nd3+, Er3+ and Yb3+ ions [17]. For example, a highly luminescent
[Er(bta)3(dppz)] (Hbta = benzoyltrifluoroacetone) complex has previously been reported [18].
It exhibited stronger NIR emission than similar complexes prepared with the Hbta ligand
and bipyridine, phenanthroline or dipyrido[3,2-d:2′,3′-f]quinoxaline. Recently, an [Yb(L)3(dppz)]
(L = 3,5-heptanedione) complex has been reported, showing strong NIR luminescence and the
incorporation of such complexes in poly(methyl methacrylate) (PMMA) thin films was studied
for potential biological applications [19]. Ytterbium(III) complexes, such as [Yb(dppz)(DMF)2Cl3] and
[Yb(dppz)(ttfa)3] (Httfa = 4,4,4-trifluoro-1-(2-thienyl)-1,3-butanedione) have been designed as NIR
bioimaging probes using cooperative upconversion luminescence for theranostic application in the
biological phototherapeutic window [20]. Another feature of polypyridyl ligands such as dppz is
their ability to interact with DNA tracts [21], rendering them perfect candidates as NIR luminescent
probes for cellular imaging and diagnostics, when combined with specific lanthanides. Here, in our
pursuit to obtain compounds with strong NIR luminescence properties we have designed complexes,
which consist of one lanthanide ion (Ln = Nd3+, Er3+ and Yb3+) and two dppz ligands. In all these
complexes the lanthanide ions are ten-coordinated by two bidentate N,N-donor dppz ligands and
three bidentate nitrate ions. We also synthesized analogous complexes with other lanthanide ions
(Ln = Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Tm3+, Lu3+) and single crystals suitable for
X-ray diffraction analysis were obtained for several of the Ln3+ complexes (Ln = La3+, Ce3+, Pr3+, Nd3+,
Eu3+, Er3+,Yb3+, Lu3+). This shows that our synthetic approach, which is novel compared to other
syntheses reported for phenazine complexes, is highly successful in yielding single crystals suitable
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for measurements of analogous structures. A detailed luminescence study of the [Nd(NO3)3(dppz)2],
[Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] complexes was carried out and is presented in this paper.
Additionally, the stability of the compounds in solution is verified by UV-Vis spectroscopy. Last,
the intercalation ability of the [Nd(NO3)3(dppz)2] with calf thymus DNA (CT-DNA) was tested using
fluorescence spectroscopy.
2. Results and Discussion
2.1. Synthesis of the Ligand and Complexes
The synthesis of the ligand precursor 1,10-phenanthroline-5,6-dione and of the dipyrido[3,2-a:
2′,3′-c]phenazine ligand are presented in the supporting information (Schemes S1 and S2).
Complexes of general formula [Ln(NO3)3(dppz)2] (Ln = Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Tb3+, Dy3+,
Ho3+, Er3+, Tm3+, Yb3+, Lu3+) were prepared by the reaction of the lanthanide nitrite salt and the dppz
ligand in 1:2 molar ratio (Scheme 1). Reactions were performed in a mixture methanol/nitromethane
at 40 ◦C, for 2 h. The complexes precipitated directly from the reaction mixture in moderate
yields. The complexes are all soluble in dimethyl sulfoxide (DMSO) and dimethylformamide (DMF).
The complexes [Ln(NO3)3(dppz)2] (Ln = La3+ and Gd3+) have previously been reported and hence are
not included in the series [22].
Scheme 1. Synthesis of the [Ln(NO3)3(dppz)2] complexes (Ln = Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Tb3+,
Dy3+, Ho3+, Er3+, Tm3+, Yb3+, Lu3+).
2.2. Spectroscopic Study
1,10-Phenantroline-5,6-dione and the dipyrido[3,2-a:2′,3′-c]phenazine (dppz) ligand were
characterized by IR and 1H-NMR spectroscopy. These compounds have already been described
in literature and the positions of the bands in the IR spectra and chemical shift values in the 1H-NMR
spectra are in accordance with the literature data [23,24] (see Materials and Methods, parts: 3.1.,
3.3.1. and 3.3.2.). The IR spectrum of 1,10-phenantroline-5,6-dione showed characteristic bands at
the following wavenumber positions: around 3062 cm−1 (C-H stretching vibrations), 1686 (C=O
stretching vibrations), 1580–1562 and 1460–1418 cm−1 (C-C and C-N stretching vibrations in the ring).
Characteristic bands of the dppz molecule were detected also at expected positions: around 3026 cm−1
(C-H stretching vibrations), 1589–1575 and 1485–1361 cm−1 (C-C and C-N stretching vibrations in
the ring).
The IR spectra of all the complexes showed characteristic bands at the following wavenumber
positions: around 3095 cm−1 (C-H stretching vibrations), 1600–1585 and 1500–1400 cm−1 (C-C and C-N
stretching vibrations in the ring), 900–675 cm−1 (out-of-plane bends).
2.3. Single Crystal X-ray Analysis
A whole series of eight [Ln(NO3)3(dppz)2] complexes (Ln = La3+, Ce3+, Pr3+, Nd3+, Eu3+,
Er3+, Yb3+ and Lu3+) were structurally characterized by single-crystal X-ray analysis. Although the
[La(NO3)3(dppz)2] complex has previously been reported [22], its crystal structure has never been
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reported and is therefore included in the reported series. All structures were found to be isomorphic
and exist as neutral, mononuclear species. Therefore, only the [Nd(NO3)3(dppz)2] complex is described
as an example.
The complex [Nd(NO3)3(dppz)2] crystallized in the centro-symmetric space group P21/c, with one
complete [Nd(NO3)3(dppz)2] complex as the asymmetric unit. The Nd3+ center is ten-coordinated
by two bidentately coordinating N,N’-donor dppz ligands and three O,O’-bidentate nitrate ligands
(Figure 1).
Figure 1. Asymmetric unit of the crystal structure of [Nd(NO3)3(dppz)2], showing thermal displacement
ellipsoids at the 50% probability level, atom labeling scheme of the hetero atoms and polyhedron
representation of the coordination environment of the Nd3+ ion.
The coordination environment around Nd3+ can be best described as a bicapped dodecahedron
geometry. As a consequence, the two dppz ligands are oppositely oriented, with an angle of 78.5◦
between the ligands. The Nd-O distances are in the range of 2.516(3) to 2.600(3) Å. The Nd-N distances
are in the range of 2.590(3) to 2.629(3) Å.
In the packing, multiple π···π stacking interactions are observed between the dppz aromatic
rings (centroid-centroid distances of 3.653(2)–3.842(2)Å for distances <4Å). Furthermore, the nitrate
ligands form N-O···π interactions with several dppz aromatic rings (N-O···centroid distances between
3.059(3)–3.931(3)Å).
An isostructural compound of the Eu3+ complex has previously been reported, however, this latter
compound crystallized in the different space group C2/c, and featured inclusions of an extra dppz
ligand and diethylether molecule in the crystal packing [25].
2.4. Photoluminescence Study
The [Ln(NO3)3(dppz)2] complexes containing spectroscopically active lanthanide ions were tested
for their luminescence properties. All measurements were carried out in the solid state. It was observed
that only the [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2], [Yb(NO3)3(dppz)2] and [Eu(NO3)3(dppz)2]
complexes displayed luminescence properties when excited into the maximum of the broad band
originating from the dppz ligand. The NIR luminescence properties of the Nd3+, Er3+ and Yb3+
complexes are discussed in detail in this paper. For the sake of completeness, the excitation and
emission spectra of the [Eu(NO3)3(dppz)2] complex are presented in the SI (Figures S1 and S2).
The singlet and triplet energy levels of the dppz ligand have been previously reported in the literature
(37000 and 18600 cm−1) [22]. It is known that the intersystem crossing process becomes effective
when ∆E (1ππ*−3ππ*), the energy difference between the first excited singlet and triplet levels of the
ligand, is more than 5000 cm−1 [26]. For the dppz ligand, the energy gap between the 1ππ* and 3ππ*
amounts to 18400 cm−1, which indicates an effective intersystem crossing process. A study of the
ligand’s triplet energy level and the resonant energy levels of the various lanthanides allows to predict
whether efficient ligand-to-metal energy transfer can occur between the chosen ligand and a particular
Molecules 2020, 25, 5309 5 of 16
lanthanide ion. The ligand triplet energy level must be obviously higher than the resonant energy level
of the lanthanide to result in adequate ligand to metal energy transfer. Of course, most likely the energy
is not transferred directly to the emitting level of the lanthanide, but to higher levels, which then relax
to the emitting levels via a nonradiative way. In Scheme 2 we present the singlet and triplet energy
levels of dppz and of some selected spectroscopically active lanthanide ions. This clearly shows that
the dppz ligand is very well suited for the design of NIR emitting Nd3+, Er3+ and Yb3+ complexes.
On the other hand, the low triplet energy level of dppz makes it rather unfavorable as a sensitizer for
most of the visible emitting lanthanide ions (e.g., Sm3+, Tb3+, Dy3+). Nevertheless, we were able to
observe visible red emission for the [Eu(NO3)3(dppz)2] complex (studied in solid state, DMF and a
DMF-H2O mixture; Figures S1 and S2).
Scheme 2. Schematic simplified energy level diagram of the dppz ligand and selected lanthanides
employed in the study. Favorable energy transfer processes from the dppz to Ln3+ ions are shown as
orange dotted arrows.
Steady-state excitation and emission spectra of the Nd3+, Er3+ and Yb3+ complexes were recorded
at room temperature. For all three complexes, the excitation spectrum consisted of a strong broad band
in the region 250–500 nm with a maximum at around 385.0 nm (Figures 2–4). For [Nd(NO3)3(dppz)2],
additionally several narrow sharp peaks were present, which could be assigned to the f-f transitions of
Nd3+ (Table 1). When exciting the [Nd(NO3)3(dppz)2] complex at 385.0 nm the three characteristic NIR
emission peaks of Nd3+ were recorded: 4F3/2→ 4I9/2 (870.8 nm), 4F3/2→ 4I11/2 (1052.7 nm), and 4F3/2→
4I13/2 (1334.5 nm). The luminescence lifetime of the complex was also recorded. The decay curve of
this compound as well as the [Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] complex could be well fitted
using the single exponential equation:







where I and I0 are the luminescence intensities at time t and 0, respectively, and τ is the luminescence
lifetime. The decay time of the [Nd(NO3)3(dppz)2] complex was determined to be 1624 ns or 1.62 µs
(Figure 5).
Figure 2. Excitation (left) and emission (right) steady-state spectra of the [Nd(NO3)3(dppz)2] complex
measured at room temperature. The labeled peaks a–d and a–c, in the excitation and emission spectrum,
respectively, have been assigned to appropriate transitions in Table 1.
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Figure 3. Excitation (left) and emission (right) steady-state spectra of the [Er(NO3)3(dppz)2] complex
measured at room temperature. The broad emission band is referred to as peak “a” in Table 1.
Figure 4. Excitation (left) and emission (right) steady-state spectra of the [Yb(NO3)3(dppz)2] complex
measured at room temperature. The broad emission band is referred to as peak “a” in Table 1.
Table 1. Assignment of the labeled transitions a-d in the steady-state excitation and emission spectra of





































no f-f transitions a 1529.0 6548 4I13/2 → 4I15/2
YbL
no f-f transitions a 977.6 10229 2F5/2 → 2F7/2
When exciting the [Er(NO3)3(dppz)2] complex at 385.0 nm one strong, broad peak located
at 1529.0 nm, which can be assigned to the 4I13/2 →4I15/2 “telecom” transition, was observed.
The luminescence lifetime was recorded for this complex and was determined as 2295 ns or 2.30 µs
(Figure 6).
Exciting the [Yb(NO3)3(dppz)2] complex at 385.0 nm resulted in a strong broad peak with a
maximum at 977.6 nm. This peak could be assigned to the 2F5/2→ 2F7/2 transition of Yb3+. The decay
time of the complex was calculated to be 9765 nm or 9.77 µs (Figure 7).
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Figure 5. Decay profile of the [Nd(NO3)3(dppz)2] complex.
Figure 6. Decay profile of the Er(dppz)2(NO3)3 complex.
Figure 7. Decay profile of the [Yb(NO3)3(dppz)2] complex.
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The fact that the decay curves of the three complexes could be well fitted by monoexponential
functions indicates the presence of single luminescence sites in the compounds, which is confirmed by
the crystal structures.
The [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2], [Yb(NO3)3(dppz)2] complexes show good
luminescence properties, confirming that the dppz ligand is very well suited for the design of
NIR emitting Nd3+, Er3+ and Yb3+ complexes. The dppz triplet level is well matched with the resonant
energy levels of the two lanthanides Nd3+ and Er3+, allowing efficient energy transfer from the ligand
to the lanthanide ions. Additionally, there are no water molecules in the first coordination sphere of
the lanthanide minimizing non-radiative deactivation. To the best of our knowledge, so far only the
luminescence properties of an [Er(bta)3(dppz)] complex have been reported for NIR-emitting lanthanide
dppz complexes [18]. This compound has a higher decay time compared to our [Er(NO3)3(dppz)2]
complex. This is quite expected due to the presence of a fluorinated Hbta ligand, as it is known
that Er3+ complexes with fluorinated ligands have exceptionally long decay times (e.g., 16.8 µs for a
complex with 1,1,1,3,5,5,5-heptafluoropentane-2,4-dione) [27,28].
2.5. UV/Vis Stability Tests
In order to enable the [Ln(NO3)3(dppz)2] complexes to have real application in biological
environment it is necessary that they remain stable in solution over a certain period of time. Therefore,
the stability of the [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] samples was tested
over a period of 6 h. As can be found in literature the electronic absorption spectra of the dppz
complexes in DMF show a ligand centered π→π* transition at around 265 nm. Two bands at 361 nm
and 380 nm assigned to the n→π* transitions of the phenazine moiety are also present in the UV/Vis
spectra [22,29]. In order to rule out decomposition of the complexes over time absorption spectral traces
of the [Nd(NO3)3(dppz)2] in DMF were measured over a period of up to 6 h (Figure 8). No significant
changes are visible in the spectra. Similar experiments were carried out for the [Er(NO3)3(dppz)2] and
[Yb(NO3)3(dppz)2] compounds and exhibited no appreciable changes in the UV/Vis spectra over time
(Figures S3 and S4). Our UV-Vis spectra are recorded in the 280–500 nm region to observe the n→π*
transitions of the phenazine moiety. The complexes were also soluble in a mixture of DMF/Tris buffer
(5 mM Tris-HCl, 5 mM NaCl, pH 7.2) and weakly soluble in only the Tris buffer (Figures S4 and S5).
Figure 8. UV-Vis absorption spectra of the [Nd(NO3)3(dppz)2] complex carried out over a range of 6 h
in DMF.
To further investigate the stability of these [Ln(NO3)3(dppz)2] complexes, we have analyzed the
[Eu(NO3)3(dppz)2] complex in different environments. It is known, that in europium compounds
the splitting of the 5D0 → 7F0–6 peaks contains information on the europium ion’s environment [2].
Therefore, europium is often referred to as a structural probe. We have performed measurements of the
[Eu(NO3)3(dppz)2] complex in solid, DMF and 50%DMF + 50%H2O mixture (see Figures S1 and S2).
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All emission spectra have been recorded upon exciting into the maximum of the dppz ligand’s
absorption band at 370 nm. As can be observed, there are some changes in the emission spectra
measured in the different environments, but it is clear that the red emission of the Eu3+ is retained even
in 50%DMF + 50%H2O. However, the excitation spectra recorded in the three cases look remarkably
similar (apart from the 5L6← 7F0 peak slightly below 400 nm in the solid state spectrum). This clearly
indicates that the Eu3+ ion remains coordinated by at least one of the dppz ligands even after dissolution
in DMF and after adding additional distilled water. In order to investigate whether indeed a different
complex would be present after dissolution in DMF or DMF/water mixture, the luminescence decay
traces were recorded in H2O and D2O to determine the number of directly coordinated water molecules
using the Horrock’s equation [30,31] (Figures S7–S10). In fact, DMF/H2O 50/50 and DMF/D2O
50/50 mixtures were used as the complex isn’t sufficiently soluble in pure H2O or D2O. This yielded a
number of coordinated water molecules of 3.73, pointing to the coordination of three or four water
molecules to the Eu3+ ion. Given the fact that at least one dppz ligand should remain coordinated
to the Eu3+ ion, simply replacing one dppz ligand with water molecules would not yield a number
of three to four directly coordinated water molecules. As the excitation spectra are almost identical
in the three cases, it is more likely that some of the nitrate ions that coordinate to the Eu3+ ion are
replaced by water or DMF molecules (the nitrates remaining in the second coordination sphere for
example) upon dissolution, resulting in a local coordination site at the Eu3+ ion that is less dissimilar
to the original one in the solid state. It can therefore be assumed that indeed changes in the complex’s
composition may occur upon dissolution in DMF or a DMF/water mixture, but most likely this does
not involve drastic rearrangements such as the loss of the dppz ligands. As all reported complexes are
isostructural, we expect similar behavior of the whole series of compounds.
2.6. CT-DNA Interaction Tests
In order to assess if the obtained [Ln(NO3)3(dppz)2] complexes show DNA interaction ability
we carried out an ethidium bromide (EthB) displacement assay with CT-DNA in the presence of the
[Nd(NO3)3(dppz)2] complex as an example. EthB is employed as a spectral probe, which shows
enhanced emission intensity when intercalated to DNA and reduced emission intensity in the free state
in water or buffer medium (due to solvent quenching of the fluorescence). The competitive interaction
of the [Nd(NO3)3(dppz)2] complex, which could result in the displacement of the CT-DNA intercalated
EthB, was monitored using fluorescence spectroscopy.
Figure 9 presents the emission spectra of EthB, EthB pretreated with CT-DNA, and EthB pretreated
with CT-DNA and increasing additions of the [Nd(NO3)3(dppz)2] complex. As noticed, based on
the figure, with increasing [Nd(NO3)3(dppz)2] concentration, the EthB emission intensity decreases.
This means that the [Nd(NO3)3(dppz)2] complex shows sufficient interaction ability to the CT-DNA.
With increasing [Nd(NO3)3(dppz)2] concentration an increased amount if EthB is displaced from the
CT-DNA and is hence in the free state in the buffer. Due to solvent quenching, a drop in the emission
intensity is clearly observed.
The apparent binding constant Kapp of the [Nd(NO3)3(dppz)2] complex to the CT-DNA was
determined using the equation KEthB [EthB] = Kapp C50, where KEthB is the binding constant
of EthB (1.0 107 M−1, [EthB] is the EthB concentration (1.27 mM) and C50 is the concentration
of the [Nd(NO3)3(dppz)2] complex at 50% reduction of the fluorescence intensity of the EthB
(323.6 µM; based on the Stern–Volmer plot of I/I0 vs [complex]; see Supplementary Materials) [20,32].
The Kapp equals 3.9 107 M−1, indicating high affinity to CT-DNA, most probably through a DNA
intercalative mode. A similar value of 1.2 107 M−1 was found for a [Pt(pydppz)Cl]Cl (pydppz =
6-(2-pyridyl)-dipyrido-[3,2-a:2′,3′-c]phenazine) complex [33], while lower values of ∼1.3–6.0 106 M−1
have often been reported for other lanthanide dppz complexes [20,25,29].
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Figure 9. Emission spectral traces of EthB bound CT-DNA with increasing [Nd(NO3)3(dppz)2] additions
(1–15 µL range; 14 mM). The measurements were carried out in 5 mM Tris-HCl/NaCl buffer (pH = 7.2)
at RT; λex = 546 nm, λem, max. = 603 nm.
3. Materials and Methods
3.1. Synthesis
All chemicals (analytical grade) were purchased from Sigma Aldrich, VWR, Acros Organics or
Merck Chemicals and used without further purification. The calf thymus DNA (CT-DNA) was Type 1,
fibers, and was purchased from Sigma Aldrich. The precursor ligand, 1,10-phenantroline-5,6-dione
and the dipyrido[3,2-a:2′,3′-c]phenazine ligand were synthesized according to literature procedures
with slight modifications [23,24].
3.2. Characterization
Elemental analysis (C, H, N) was carried out with a Thermo Scientific Flash 2000 Series
CHNS/O analyzer.
IR spectra were recorded from 4000 to 650 cm−1, on a Thermo Scientific FT-IR spectrometer
(type Nicolet 6700), equipped with a DRIFTS-cell, using KBr as a non-absorbing matrix.
Photoluminescence measurements were recorded on an Edinburgh Instruments FLSP920
UV/Vis-NIR spectrofluorometer, using a 450 W xenon lamp as the steady state excitation source
and a Hamamatsu R5509-72 photomultiplier operating at −80 ◦C. For the Eu3+ spectrum, a Hamamatsu
R928P PMT was used, for the 200–900 nm range. The time-resolved measurements were performed
using a Continuum Surelite I laser (450 mJ @1064 nm), operating at a repetition rate of 10 Hz and using
the third harmonic (355 nm) as the excitation source, and the photomultiplier detector mentioned
above. For all compounds, the luminescence of solid samples was recorded. Small amounts of the
powder were placed between quartz plates.
UV/Vis measurements were performed on a Lambda 950 UV/Vis-NIR spectrophotometer from
Perkin Elmer employing quartz cuvettes with a 10 mm path length.
NMR spectra were recorded in DMSO-d6, on a Bruker Avance 300 MHz or 500 MHz and all
chemical shifts are given relative to tetramethylsilane (TMS).
3.3. Synthesis of the Ligand
3.3.1. Synthesis of the Ligand Precursor 1,10-phenanthroline-5,6-dione (Phendione)
1,10-Phenanthroline (55.5 mmol) was added in small portions under stirring to sulfuric acid (65%,
80 mL) and left to dissolve at room temperature. Potassium bromate (62 mmol) was added in portions
over a period of 3 h and the mixture was stirred at room temperature for 24 h. Then, the mixture was
poured over ice and was neutralized to pH 7 using sodium carbonate. The mixture was extracted with
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chloroform and the organic phase was dried over magnesium sulfate during the night. The solution
was then filtered and evaporated to dryness. The crude product was recrystallized from methanol to
obtain the desired yellow product.
Yield: 8.4 g (71.8%).
IR (KBr, cm−1): 3062, 1686, 1580, 1562, 1460, 1418, 1290, 1205, 1116, 923, 816, 747.
1H-NMR (500 MHz, DMSO-d6) δ ppm 7.70 (dd, 2H, J = 8.1, 4.8 Hz); 8.40 (dd, 2H, J = 8.1, 1.8 Hz);
8.99 (dd, 2H, J = 4.8, 1.8 Hz).
3.3.2. Synthesis of the Ligand Dipyrido[3,2-a:2′,3′-c]phenazine (dppz)
Phendione (0.24 mmol) was dissolved in ethanol (96%, 4 mL) at 75 ◦C, o-phenylenediamine
(0.24 mmol) was added and the mixture was heated for 30 min under reflux. After cooling to room
temperature, the dppz ligand was precipitated. The product was isolated, washed with methanol and
dried under vacuum.
Yield: 50 mg (73.5%).
IR (KBr, cm−1): 3026, 1589, 1575, 1485, 1477, 1445, 1405, 1361, 1125, 1208, 1112, 1072, 1053, 1029,
922, 847, 836, 807, 739.
1H-NMR (500 MHz, DMSO-d6) δ ppm 7.97 (dd, 2H, J = 8.1, 4.4 Hz); 8.09 (m, 2H); 8.42 (m, 2H);
9.24 (dd, 2H, J = 4.3, 1.8 Hz); 9.56 (m, 2H).
3.4. Synthesis of the Complexes
The starting lanthanide nitrate salt (0.06 mmol) was dissolved in a mixture of nitromethane/
methanol (1/1, 12 mL) and heated at 40 ◦C. To this, a solution of dppz ligand (0.12 mmol) in warm
methanol (8 mL) was added dropwise with stirring, and the reaction mixture was left for 2 h, at 40 ◦C.
During that period, the desired complex precipitated. The product was filtered off, washed with
nitromethane (2 mL), water (1 mL) and ether (2 mL) and dried under reduced pressure. The filtrate
was set up for crystallization via vapor diffusion of acetonitrile or isopropanol as antisolvents.
(C18H10N4)2Ce(NO3)3·H2O (1).
Yield: 30 mg (55%). Anal. Calcd. for (C18H10N4)2Ce(NO3)3·H2O, %: C 47.58, H 2.44, N 16.95.
Found, %: C 47.79, H 2.00, N 16.35. IR (KBr, cm−1): 3100–3580, 3095, 1586, 1578, 1494, 1441, 1420, 1364,
1340, 1303, 1231, 1137, 1128, 1079, 1047, 1034, 844, 813, 795, 776.
(C18H10N4)2Pr(NO3)3·0.25H2O) (2).
Yield: 35 mg (65%). Anal. Calcd. for (C18H10N4)2Pr(NO3)3·0.25H2O, %: C 48.26, H 2.31, N 17.20.
Found, %: C 47.94, H 2.04, N 16.65. IR (KBr, cm−1): 3570, 3095, 1599, 1586, 1577, 1498, 1440, 1420, 1364,
1340, 1303, 1231, 1137, 1128, 1079, 1046, 1032, 844, 822, 795, 762.
(C18H10N4)2Nd(NO3)3·0.5H2O (3).
Yield: 31 mg (57%). Anal. Calcd. for (C18H10N4)2Nd(NO3)3·0.5H2O, %: C 47.84, H 2.34, N 17.05.
Found, %: C 47.67, H 2.00, N 16.45. IR (KBr, cm−1): 3094, 1597, 1584, 1576, 1493, 1442, 1421, 1365, 1340,
1302, 1236, 1137, 1129, 1079, 1048, 1033, 845, 822, 791, 761.
(C18H10N4)2Sm(NO3)3·0.75H2O (4).
Yield: 30 mg (55%). Anal. Calcd. for (C18H10N4)2Sm(NO3)3·0.75H2O, %: C 47.28, H 2.37, N 16.85.
Found, %: C 46.96, H 1.89, N 16.29. IR (KBr, cm−1): 3100-3560, 3095, 1600, 1586, 1578, 1497, 1441, 1420,
1363, 1340, 1302, 1231, 1137, 1128, 1079, 1047, 1034, 843, 822, 795, 776, 762.
(C18H10N4)2Eu(NO3)3·0.5H2O (5).
Yield: 36 mg (66%). Anal. Calcd. for (C18H10N4)2Eu(NO3)3·0.5H2O, %: C 47.43, H 2.32, N 16.90.
Found, %: C 47.28, H 1.88, N 16.34. IR (KBr, cm−1): 3400-3560, 3095, 1600, 1586, 1577, 1497, 1490, 1473,
1441, 1420, 1363, 1340, 1309, 1230, 1137, 1127, 1079, 1047, 1035, 844, 822, 795, 775, 762.
(C18H10N4)2Tb(NO3)3·0.25H2O (6).
Yield: 35 mg (64%). Anal. Calcd. for (C18H10N4)2Tb(NO3)3·0.25H2O, %: C 47.30, H 2.26, N 16.86.
Found, %: C 46.89, H 1.97, N 16.34. IR (KBr, cm−1): 3400-3560, 3096, 1600, 1589, 1576, 1496, 1490, 1473,
1441, 1419, 1364, 1339, 1308, 1231, 1138, 1126, 1077, 1047, 1036, 844, 822, 795, 776, 762.
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(C18H10N4)2Dy(NO3)3·0.25H2O (7).
Yield: 36 mg (65%). Anal. Calcd. for (C18H10N4)2Dy(NO3)3·0.25H2O, %: C 47.12, H 2.25, N 16.79.
Found, %: C 46.60, H 1.96, N 16.34. IR (KBr, cm−1): 3450-3560, 3095, 1600, 1586, 1577, 1497, 1441, 1420,
1363, 1340, 1301, 1230, 1188, 1127, 1078, 1046, 1033, 822, 813, 776, 762, 737.
(C18H10N4)2Ho(NO3)3·0.25H2O (8).
Yield: 31 mg (56%). Anal. Calcd. for (C18H10N4)2Ho(NO3)3·0.25H2O, %: C 47.00, H 2.25, N 16.75.
Found, %: C 46.41, H 1.96, N 16.20. IR (KBr, cm−1): 3100–3560, 3096, 1600, 1589, 1574, 1494, 1443, 1423,
1361, 1341, 1302, 1234, 1189, 1125, 1074, 1044, 1031, 821, 815, 771, 760, 734.
(C18H10N4)2Er(NO3)3·0.25H2O (9).
Yield: 37 mg (67%). Anal. Calcd. for (C18H10N4)2Er(NO3)3·0.25H2O, %: C 46.88, H 2.24, N 16.70.
Found, %: C 46.49, H 1.98, N 16.14. IR (KBr, cm−1): 3400-3560, 3097, 1601, 1586, 1577, 1498, 1489, 1443,
1420, 1363, 1339, 1312, 1231, 1189, 1138, 1080, 1047, 1029, 822, 812, 773, 763, 737.
(C18H10N4)2Tm(NO3)3·0.5H2O (10).
Yield: 34 mg (61%). Anal. Calcd. for (C18H10N4)2Tm(NO3)3·0.5H2O, %: C 46.57, H 2.28, N 16.59.
Found, %: C 46.30, H 1.88, N 16.02. IR (KBr, cm−1): 3550, 3096, 1601, 1586, 1578, 1498, 1489, 1441, 1420,
1364, 1340, 1309, 1231, 1188, 1138, 1127, 1079, 1047, 1035, 1026, 822, 813, 777, 762, 738.
(C18H10N4)2Yb(NO3)3·0.5H2O (11).
Yield: 29 mg (52%). Anal. Calcd. for (C18H10N4)2Yb(NO3)3·0.5H2O, %: C 46.36, H 2.27, N 16.52.
Found, %: C 46.10, H 1.99, N 15.99. IR (KBr, cm−1): 3350-3560, 3093, 1600, 1584, 1579, 1495, 1488, 1440,
1421, 1364, 1341, 1313, 1230, 1186, 1132, 1126, 1073, 1046, 1036, 1025, 821, 815, 773, 761, 738.
(C18H10N4)2Lu(NO3)3·0.5H2O (12).
Yield: 28 mg (50%). Anal. Calcd. for (C18H10N4)2Lu(NO3)3·0.5H2O, %: C 46.26, H 2.26, N 16.49.
Found, %: C 46.09, H 1.96, N 15.97. IR (KBr, cm−1): 3350-3550, 3095, 1600, 1582, 1578, 1492, 1487, 1441,
1425, 1362, 1342, 1314, 1231, 1184, 1131, 1123, 1071, 1046, 1036, 1024, 821, 813, 777, 767, 732.
1H-NMR (300 MHz, DMSO-d6) δ ppm 7.95 (dd, 2H, J = 8.3, 4.5 Hz); 8.06 (m, 2H); 8.38 (m, 2H);
9.22 (dd, 2H, J = 4.5, 1.9 Hz); 9.54 (dd, 2H, J = 8.3, 1.9 Hz).
13C-NMR (75 MHz, DMSO-d6) δ 124.6; 127.0; 129.2; 131.3; 133.1; 140.8; 141.8; 147.8; 152.4.
3.5. Solubility and Stability of Complexes
The [Ln(NO3)3(dppz)2] complexes were soluble in DMF and DMSO. The solution stability of the
[Ln(NO3)3(dppz)2] (Ln = Nd3+, Er3+,Yb3+) in DMF was tested. The solubility in DMF/buffer mixtures
(5 mM Tris-HCl, 5 mM NaCl, pH 7.2) was additionally tested.
3.6. Single Crystal X-ray Diffraction Analysis
For all reported structures, X-ray intensity data were collected, at 100 K, on a Rigaku Oxford
Diffraction Supernova Dual Source (Cu at zero) diffractometer equipped with an Atlas charge-coupled
device (CCD) detector usingω scans and CuKα (λ = 1.54184 Å) radiation. The images were interpreted
and integrated with the program CrysAlisPro (Rigaku Oxford Diffraction) [34]. Using Olex2 [35],
the structures were solved by direct methods using the ShelXS structure solution program and refined
by full-matrix least-squares on F2 using the ShelXL program package [36,37]. Nonhydrogen atoms
were anisotropically refined and the hydrogen atoms in the riding mode and isotropic temperature
factors fixed at 1.2 times U(eq) of the parent atoms. For all reported structures, a correction for diffuse
effects, due to the inclusion of disordered water molecules, was made using the SQUEEZE routine in
PLATON [38].
Crystal data for compound: C36H20LaN11O9, M = 889.54, monoclinic, space group P21/c (No. 14),
a = 9.5038(4) Å, b = 14.3572(6) Å, c = 25.1669(12) Å, β = 91.800(4)◦, V = 3432.3(3) Å3, Z = 4, T = 100 K,
ρcalc = 1.721 g cm−3, µ(Cu-Kα) = 10.278 mm−1, F(000) = 1768, 29511 reflections measured, 6908 unique
(Rint = 0.0951) which were used in all calculations. The final R1 was 0.0666 (I>2σ(I)) and wR2 was
0.2016 (all data).
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Crystal data for compound (1): C36H20CeN11O9, M = 890.75, monoclinic, space group P21/c
(No. 14), a = 9.4873(3) Å, b = 14.4189(5) Å, c = 25.1531(6) Å, β = 91.896(2)◦, V = 3438.97(18) Å3, Z = 4,
T = 100 K, ρcalc = 1.720 g cm−3, µ(Cu-Kα) = 10.886 mm−1, F(000) = 1772, 20269 reflections measured,
6902 unique (Rint = 0.0674) which were used in all calculations. The final R1 was 0.0518 (I>2σ(I)) and
wR2 was 0.1398 (all data).
Crystal data for compound (2): C36H20N11O9Pr, M = 891.54, monoclinic, space group P21/c
(No. 14), a = 9.46171(12) Å, b = 14.4654(2) Å, c = 25.0861(3) Å, β = 91.9166(12)◦, V = 3431.55(8) Å3, Z = 4,
T = 100 K, ρcalc = 1.726 g cm−3, µ(Cu-Kα) = 11.550 mm−1, F(000) = 1776, 26255 reflections measured,
6881 unique (Rint = 0.0497) which were used in all calculations. The final R1 was 0.0352 (I>2σ(I)) and
wR2 was 0.0924 (all data).
Crystal data for compound (3): C36H20N11NdO9, M = 894.87, monoclinic, space group P21/c
(No. 14), a = 9.4493(2) Å, b = 14.5407(4) Å, c = 24.9067(7) Å, β = 92.053(3)◦, V = 3419.97(15) Å3, Z = 4,
T = 100 K, ρcalc = 1.738 g cm−3, µ(Cu-Kα) = 12.244 mm−1, F(000) = 1780, 23245 reflections measured,
6884 unique (Rint = 0.0409) which were used in all calculations. The final R1 was 0.0374 (I>2σ(I)) and
wR2 was 0.1018 (all data).
Crystal data for compound (5): C36H20EuN11O9, M = 902.60, monoclinic, space group P21/c
(No. 14), a = 9.3990(2) Å, b = 14.6262(4) Å, c = 24.8352(6) Å, β = 91.972(2)◦, V = 3412.11(14) Å3, Z = 4,
T = 100 K, ρcalc = 1.757 g cm−3, µ(Cu-Kα) = 13.820 mm−1, F(000) = 1792, 21978 reflections measured,
6860 unique (Rint = 0.0667) which were used in all calculations. The final R1 was 0.0480 (I>2σ(I)) and
wR2 was 0.1326 (all data).
Crystal data for compound (9): C36H20ErN11O9, M = 917.89, monoclinic, space group P21/c
(No. 14), a = 9.3230(2) Å, b = 14.7818(7) Å, c = 24.6058(10) Å, β = 91.848(3)◦, V = 3389.2(2) Å3, Z = 4,
T = 100 K, ρcalc = 1.799 g cm−3, µ(Cu-Kα) = 5.262 mm−1, F(000) = 1812, 19595 reflections measured,
6746 unique (Rint = 0.0773) which were used in all calculations. The final R1 was 0.0597 (I>2σ(I)) and
wR2 was 0.1667 (all data).
Crystal data for compound (11): C36H20N11O9Yb, M = 923.67, monoclinic, space group P21/c
(No. 14), a = 9.3018(3) Å, b = 14.8195(5) Å, c = 24.5502(6) Å, β = 91.654(2)◦, V = 3382.79(18) Å3, Z = 4,
T = 100 K, ρcalc = 1.814 g cm−3, µ(Cu-Kα) = 5.781 mm−1, F(000) = 1820, 20841 reflections measured,
6619 unique (Rint = 0.0766) which were used in all calculations. The final R1 was 0.0498 (I>2σ(I)) and
wR2 was 0.1331 (all data).
Crystal data for compound (12): C36H20LuN11O9, M = 925.60, monoclinic, space group P21/c
(No. 14), a = 9.2924(2) Å, b = 14.8631(5) Å, c = 24.4840(7) Å, β = 91.488(2)◦, V = 3380.44(17) Å3, Z = 4,
T = 100 K, ρcalc = 1.819 g cm−3, µ(Cu-Kα) = 6.258 mm−1, F(000) = 1824, 25239 reflections measured,
6807 unique (Rint = 0.0590) which were used in all calculations. The final R1 was 0.0375 (I>2σ(I)) and
wR2 was 0.1012 (all data).
CCDC2034576-2034583 contain the supplementary crystallographic data for this paper and can
be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge
Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44-1223-336033;
or deposit@ccdc.cam.ac.uk).
3.7. CT-DNA Binding Study
CT-DNA was dissolved in Tris-HCl/NaCl buffer (5 mM, pH = 7.2). The DNA was left for several
hours to completely dissolve, no sonication was used. The ratio of the absorbance values of the CT-DNA
at 260 and 280 nm was ∼1.9, confirming the CT-DNA is free from protein impurities. The CT-DNA
concentration was determined by absorption spectroscopy using a molar absorption coefficient value
of 6600 M−1 cm−1 at 260 nm for CT-DNA [29]. The initial concentration of the CT-DNA was determined
to 14.15 mM. The EthB was also dissolved in the Tris-HCl/NaCl buffer (5 mM, pH = 7.2) to obtain
an initial concentration of 2.54 mM. Subsequently, 250 µL of both the CT-DNA and EthB solutions
were added in a quartz cuvette (Starna cuvette type 23/Q/10) with a path length of 10 mm yielding a
[CT-DNA] = 7.26 mM and [EthB] = 1.27 mM. The tested [Nd(NO3)3(dppz)2] complex was dissolved in
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DMF (14 mM) and the appropriate amount was used for the DNA binding study. The competitive
binding assay from EthB displacement was carried out by measuring the emission intensities of EthB
bound to CT-DNA solution with the gradual increase of the complex concentrations (27.9–406.9 µM;
taking into account the dilution). The EthB was excited at 546 nm and observed at 603 nm (emission
maximum). EthB showed very weak emission in the Tris-buffer due to fluorescent quenching of the
free EthB in buffer. CT-DNA-bound EthB showed significant enhancement in emission intensity.
4. Conclusions
Herein, we report the synthetic procedures and the spectroscopic and single crystal X-ray diffraction
characteristics for a series of lanthanide complexes containing dipyrido[3,2-a:2′,3′-c]phenazine (dppz)
as ligand. Our synthetic approach is novel and is able to afford single crystals suitable for X-ray
diffraction analysis for most of the compounds in the lanthanide series. X-ray analysis of the complexes
reveals that all complexes are isomorphic, with the lanthanide ion coordinated by two dppz ligands
and three nitrate anions. As it could be expected based on the T1 state of the ligand (18400 cm−1)
and the resonant energy level of the studied lanthanides (Nd3+, Er3+, Yb3+), it was shown that the
dppz ligand is an appropriate choice for the design of NIR emitting complexes. We have additionally
studied the stability of the [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] complexes
in solution over a period of time. No visible changes in the UV/Vis spectra were observed up to 6 h.
Last, we have confirmed that the exemplary [Nd(NO3)3(dppz)2] complex shows DNA intercalation
ability through an ethidium bromide displacement assay carried out with CT-DNA. These results point
out that such carefully developed lanthanide polypyridyl complexes could serve as potential NIR
luminescent probes for bioimaging applications and diagnostics.
Supplementary Materials: The following are available online, Scheme S1: Synthesis of 1,10-phenanthroline-5,
6-dione. Scheme S2: Synthesis of dipyrido[3,2-a:2′,3′-c]phenazine. Figure S1: Steady-state excitation spectrum of
Eu(dppz)2(NO3)3, recorded at room temperature. Figure S2: Steady-state emission spectrum of Eu(dppz)2(NO3)3
at room temperature. Figure S3: UV-Vis absorption spectra of the [Er(dppz)2 (NO3)3] complex carried out over a
range of 6 h in DMF. Figure S4: UV-Vis absorption spectra of the [Yb(dppz)2 (NO3)3] complex carried out over a
range of 6 h in DMF. Figure S5: UV/Vis absorption spectrum of [Yb(NO3)3(dppz)2] complex dissolved in DMF:
Tris buffer (5 mM Tris-HCl, 5 mM NaCl, pH = 7.2) in a 1: 1 ratio. The UV-Vis spectrum was recorded 2 h after
dissolving the sample. Figure S6: UV-Vis absorption spectrum of [Yb(dppz)2(NO3)3] complex dissolved in Tris
buffer (5 mM Tris-HCl, 5 mM NaCl, pH = 7.2). The UV/Vis spectrum was recorded 2 h after dissolving the sample.
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